Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Endo International plcENDP · Entity 124463 | EVP & Pres,Global Comm Ops | March 29, 2022 | March 31, 2022 |
| Indivior Pharmaceuticals, Inc.INDV · Entity 4040 | Chief Commercial Officer | February 10, 2026 | February 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Endo International plc
Report date March 29, 2022 · Filed March 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 169,711 |
Ending reported balance
After 2022-03-30 transaction · row 4
3 source rows · reconciled sequenceRow 1 · 2022-03-29 · Tax withholding · Disposed 4,141 · Balance 157,729 F1: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2022. F2: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3: Represents the vesting price which is the average of the high and low share price on March 29, 2022. Row 3 · 2022-03-30 · Exercise / conversion · Acquired 16,957 · Balance 174,686 F4: On March 30, 2022, based on performance against target levels with respect to Mr. Barry's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 16,957 ordinary shares. Of this amount, 4,975 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F7: This represents the automatic conversion of performance share units granted to Mr. Barry on March 29, 2019 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement. Row 4 · 2022-03-30 · Tax withholding · Disposed 4,975 · Balance 169,711 F4: On March 30, 2022, based on performance against target levels with respect to Mr. Barry's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 16,957 ordinary shares. Of this amount, 4,975 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F8: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of performance share units. F3: Represents the vesting price which is the average of the high and low share price on March 29, 2022. |
| Stock Incentive Plan Performance Share UnitsSEC Table I · non-derivative | Direct | 286,826 |
Reported balance
After 2022-03-30 transaction · row 2
1 source rowRow 2 · 2022-03-30 · Exercise / conversion · Disposed 42,341 · Balance 286,826 F4: On March 30, 2022, based on performance against target levels with respect to Mr. Barry's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 16,957 ordinary shares. Of this amount, 4,975 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F5: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over a cumulative three-year period, each as determined by Endo International plc's Board of Directors at the end of such periods. F6: These securities were granted to Mr. Barry in consideration of his services as a senior executive of Endo International plc. |
Filing footnotes · ownership attribution and instrument terms
F1: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2022.
F2: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs.
F3: Represents the vesting price which is the average of the high and low share price on March 29, 2022.
F4: On March 30, 2022, based on performance against target levels with respect to Mr. Barry's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 16,957 ordinary shares. Of this amount, 4,975 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry.
F5: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over a cumulative three-year period, each as determined by Endo International plc's Board of Directors at the end of such periods.
F6: These securities were granted to Mr. Barry in consideration of his services as a senior executive of Endo International plc.
F7: This represents the automatic conversion of performance share units granted to Mr. Barry on March 29, 2019 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement.
F8: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of performance share units.
Indivior Pharmaceuticals, Inc.
Report date February 10, 2026 · Filed February 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,380 |
Reported balance
After 2026-02-10 transaction · row 1
1 source rowRow 1 · 2026-02-10 · Grant · Acquired 31,380 · Balance 31,380 F1: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2026 Filed Feb 12, 2026 21:03 UTC | Indivior Pharmaceuticals, Inc. INDV · Entity 4040 | GrantCommon Stock | 31,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001733376-26-000004 · wk-form4_1770930228.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,380 F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 16:09 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 4,975 | $2.52 | $12,537.00 |
DisclosureSEC source: 0001593034-22-000032 · wf-form4_164875737161921.xml · nonDerivative · entry 4 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,711 F4 · date: On March 30, 2022, based on performance against target levels with respect to Mr. Barry's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 16,957 ordinary shares. Of this amount, 4,975 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F8 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of performance share units. F3 · price: Represents the vesting price which is the average of the high and low share price on March 29, 2022. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 16:09 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionOrdinary Shares | 16,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-22-000032 · wf-form4_164875737161921.xml · nonDerivative · entry 3 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,686 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On March 30, 2022, based on performance against target levels with respect to Mr. Barry's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 16,957 ordinary shares. Of this amount, 4,975 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F7 · price: This represents the automatic conversion of performance share units granted to Mr. Barry on March 29, 2019 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 16:09 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionStock Incentive Plan Performance Share Units | 42,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-22-000032 · wf-form4_164875737161921.xml · nonDerivative · entry 2 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On March 30, 2022, based on performance against target levels with respect to Mr. Barry's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 16,957 ordinary shares. Of this amount, 4,975 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F5 · shares: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over a cumulative three-year period, each as determined by Endo International plc's Board of Directors at the end of such periods. F6 · price: These securities were granted to Mr. Barry in consideration of his services as a senior executive of Endo International plc. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 16:09 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 4,141 | $2.52 | $10,435.32 |
DisclosureSEC source: 0001593034-22-000032 · wf-form4_164875737161921.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,729 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2022. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on March 29, 2022. Read SEC document |
| March 05, 2022 Filed Mar 8, 2022 16:07 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 7,853 | $2.34 | $18,395.65 |
DisclosureSEC source: 0001593034-22-000022 · wf-form4_164677361771257.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,757 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's March 5, 2021 grant of restricted stock units (RSUs) vested on March 5, 2022. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on March 4, 2022, the last trading day prior to vesting. Read SEC document |
| April 06, 2021 Filed Apr 6, 2021 16:55 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 12,898 | $7.37 | $95,058.26 |
DisclosureSEC source: 0001593034-21-000052 · wf-form4_161774244555227.xml · nonDerivative · entry 4 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,660 F4 · date: On April 6, 2021, based on performance against target levels with respect to Mr. Barry's April 2, 2018 grant of performance share units, these awards were released and the performance share units were converted into 29,230 ordinary shares. Of this amount, 12,898 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F8 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of performance share units. F3 · price: Represents the vesting price which is the average of the high and low share price on April 1, 2021, the last trading day prior to vesting. Read SEC document |
| April 06, 2021 Filed Apr 6, 2021 16:55 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionOrdinary Shares | 29,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-21-000052 · wf-form4_161774244555227.xml · nonDerivative · entry 3 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On April 6, 2021, based on performance against target levels with respect to Mr. Barry's April 2, 2018 grant of performance share units, these awards were released and the performance share units were converted into 29,230 ordinary shares. Of this amount, 12,898 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F7 · price: This represents the automatic conversion of performance share units granted to Mr. Barry on April 2, 2018 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement. Read SEC document |
| April 06, 2021 Filed Apr 6, 2021 16:55 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionStock Incentive Plan Performance Share Units | 23,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-21-000052 · wf-form4_161774244555227.xml · nonDerivative · entry 2 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On April 6, 2021, based on performance against target levels with respect to Mr. Barry's April 2, 2018 grant of performance share units, these awards were released and the performance share units were converted into 29,230 ordinary shares. Of this amount, 12,898 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F5 · shares: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over three successive one-year periods, each as determined by Endo International plc's Board of Directors at the end of such periods. F6 · price: These securities were granted to Mr. Barry in consideration of his services as a senior executive of Endo International plc. Read SEC document |
| April 02, 2021 Filed Apr 6, 2021 16:55 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 10,508 | $7.37 | $77,443.96 |
DisclosureSEC source: 0001593034-21-000052 · wf-form4_161774244555227.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,328 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's April 2, 2018 grant of restricted stock units (RSUs) vested on April 2, 2021. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on April 1, 2021, the last trading day prior to vesting. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 6,229 | $7.31 | $45,552.05 |
DisclosureSEC source: 0001593034-21-000039 · wf-form4_161722106142702.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,027 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2021. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on March 29, 2021. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 16:49 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Restricted Stock Units (RSU) | 68,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-21-000022 · wf-form4_161532656129778.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,884 F1 · security: Upon each vesting date, each vested restricted stock unit (RSU) automatically converts into one (1) ordinary share of Endo International plc. One-third (1/3) of these RSUs generally vest, and thus expire, on each of March 5, 2022, March 5, 2023 and March 5, 2024. F2 · price: These RSUs were granted to Mr. Barry in consideration of his services as Executive Vice President and President, Global Commercial Operations of Endo International plc. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 16:10 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 5,435 | $3.40 | $18,479.00 |
DisclosureSEC source: 0001593034-20-000073 · wf-form4_159726299600788.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,142 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's August 10, 2017 grant of restricted stock units (RSUs) vested on August 10, 2020. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on August 10, 2020. Read SEC document |
| April 02, 2020 Filed Apr 6, 2020 16:08 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 6,936 | $3.16 | $21,917.76 |
DisclosureSEC source: 0001593034-20-000037 · wf-form4_158620368867755.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Pres,Global Comm Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,077 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's April 2, 2018 grant of restricted stock units (RSUs) vested on April 2, 2020. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on April 2, 2020. Read SEC document |
| March 29, 2020 Filed Mar 31, 2020 16:17 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 4,112 | $3.52 | $14,474.24 |
DisclosureSEC source: 0001593034-20-000031 · wf-form4_158568582434007.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,204 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2020. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on March 27, 2020, the last trading day prior to vesting. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 16:35 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 3,758 | $6.19 | $23,262.02 |
DisclosureSEC source: 0001593034-20-000009 · wf-form4_158266653329349.xml · nonDerivative · entry 4 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,202 F4 · date: On February 25, 2020, based on performance against target levels with respect to Mr. Barry's February 21, 2017 grant of performance share units, these awards were released and the performance share units were converted into 13,199 ordinary shares. Of this amount, 3,758 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F8 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of performance share units. F3 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2020. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 16:35 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionOrdinary Shares | 13,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-20-000009 · wf-form4_158266653329349.xml · nonDerivative · entry 3 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On February 25, 2020, based on performance against target levels with respect to Mr. Barry's February 21, 2017 grant of performance share units, these awards were released and the performance share units were converted into 13,199 ordinary shares. Of this amount, 3,758 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F7 · price: This represents the automatic conversion of performance share units granted to Mr. Barry on February 21, 2017 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 16:35 UTC | Endo International plc ENDP · Entity 124463 | Exercise / conversionStock Incentive Plan Performance Share Units | 14,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001593034-20-000009 · wf-form4_158266653329349.xml · nonDerivative · entry 2 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · date: On February 25, 2020, based on performance against target levels with respect to Mr. Barry's February 21, 2017 grant of performance share units, these awards were released and the performance share units were converted into 13,199 ordinary shares. Of this amount, 3,758 ordinary shares were withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Barry. F5 · shares: Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over three successive one-year periods, each as determined by Endo International plc's Board of Directors at the end of such periods. F6 · price: These securities were granted to Mr. Barry in consideration of his services as a senior executive of Endo International plc. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 16:35 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 1,367 | $6.19 | $8,461.73 |
DisclosureSEC source: 0001593034-20-000009 · wf-form4_158266653329349.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,761 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's February 21, 2017 grant of restricted stock units (RSUs) vested on February 21, 2020. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2020. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 16:02 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 2,619 | $4.95 | $12,964.05 |
DisclosureSEC source: 0001593034-19-000051 · wf-form4_157540695181962.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,327 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's December 1, 2016 grant of restricted stock units (RSUs) vested on December 1, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on November 29, 2019, the last trading day prior to vesting. Read SEC document |
| August 10, 2019 Filed Aug 13, 2019 17:52 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 3,560 | $2.49 | $8,864.40 |
DisclosureSEC source: 0001593034-19-000036 · wf-form4_156573310529470.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,940 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's August 10, 2017 grant of restricted stock units (RSUs) vested on August 10, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on August 9, 2019, the last trading day prior to vesting. Read SEC document |
| April 02, 2019 Filed Apr 4, 2019 16:33 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 10,508 | $8.10 | $85,114.80 |
DisclosureSEC source: 0001209191-19-023655 · doc4.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's April 2, 2018 grant of restricted stock units (RSUs) vested on April 2, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on April 2, 2019. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 16:12 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Restricted Stock Units (RSU) | 42,341 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-022391 · doc4.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,576 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. One-third (1/3) of these restricted stock units (RSUs) generally vest, thus expire, on each of March 29, 2020, March 29, 2021 and March 29, 2022. F2 · price: These RSUs were granted to Mr. Barry in consideration of his services as Executive Vice President and Chief Commercial Officer, US Branded Business of Endo International plc. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 16:46 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 1,621 | $10.38 | $16,825.98 |
DisclosureSEC source: 0001209191-19-013008 · doc4.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,698 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's February 21, 2017 grant of restricted stock units (RSUs) vested on February 21, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2019. Read SEC document |
| December 01, 2018 Filed Dec 3, 2018 16:29 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 2,609 | $12.04 | $31,412.36 |
DisclosureSEC source: 0001209191-18-060574 · doc4.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,518 F1 · date: Thirty-three and a third percent (33 1/3%) of Mr. Barry's December 1, 2016 grant of restricted stock units (RSUs) vested on December 1, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on November 30, 2018, the last trading day prior to vesting. Read SEC document |
| August 10, 2018 Filed Aug 14, 2018 16:08 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 3,560 | $15.82 | $56,319.20 |
DisclosureSEC source: 0001209191-18-046587 · doc4.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,120 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Barry's August 10, 2017 grant of restricted stock units (RSUs) vested on August 10, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Barry's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on August 10, 2018. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 14:46 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Restricted Stock Units (RSU) | 71,428 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-023551 · doc4.xml · nonDerivative · entry 1 Barry Patrick A · CIK 0001733376 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,543 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. One-third (1/3) of these restricted stock units (RSUs) generally vest, thus expire, on each of April 2, 2019, April 2, 2020 and April 2, 2021. F2 · price: These RSUs were granted to Mr. Barry in consideration of his services as Executive Vice President and Chief Commercial Officer, US Branded Business of Endo International plc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.